These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37801493)

  • 21. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
    Song D; Wang X
    J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions.
    Cui H; Sun Y; Zhao D; Zhang X; Kong H; Hu N; Wang P; Zuo X; Fan W; Yao Y; Fu B; Tian J; Wu M; Gao Y; Ning S; Zhang L
    J Transl Med; 2023 Jan; 21(1):44. PubMed ID: 36694240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-based radiogenomic analysis dissects intratumor heterogeneity and predicts prognosis of colorectal cancer: a multi-institutional retrospective study.
    Zhong ME; Duan X; Ni-Jia-Ti MY; Qi H; Xu D; Cai D; Li C; Huang Z; Zhu Q; Gao F; Wu X
    J Transl Med; 2022 Dec; 20(1):574. PubMed ID: 36482390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.
    Gyanchandani R; Lin Y; Lin HM; Cooper K; Normolle DP; Brufsky A; Fastuca M; Crosson W; Oesterreich S; Davidson NE; Bhargava R; Dabbs DJ; Lee AV
    Clin Cancer Res; 2016 Nov; 22(21):5362-5369. PubMed ID: 27185370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features.
    Li J; Qiu Z; Zhang C; Chen S; Wang M; Meng Q; Lu H; Wei L; Lv H; Zhong W; Zhang X
    Eur Radiol; 2023 Feb; 33(2):893-903. PubMed ID: 36001124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence.
    Chitalia RD; Rowland J; McDonald ES; Pantalone L; Cohen EA; Gastounioti A; Feldman M; Schnall M; Conant E; Kontos D
    Clin Cancer Res; 2020 Feb; 26(4):862-869. PubMed ID: 31732521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Associations between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center Radiogenomic Study.
    Ming W; Zhu Y; Li F; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.
    Mishra R
    Pathol Res Pract; 2024 Jan; 253():154953. PubMed ID: 38039738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMAGGS: a radiogenomic framework for identifying multi-way associations in breast cancer subtypes.
    Liang S; Xu S; Zhou S; Chang C; Shao Z; Wang Y; Chen S; Huang Y; Guo Y
    J Genet Genomics; 2024 Apr; 51(4):443-453. PubMed ID: 37783335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
    Nam KJ; Park H; Ko ES; Lim Y; Cho HH; Lee JE
    Medicine (Baltimore); 2019 Jun; 98(23):e15871. PubMed ID: 31169691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis.
    Yu T; Gao X; Zheng Z; Zhao X; Zhang S; Li C; Liu G
    Front Oncol; 2021; 11():744064. PubMed ID: 34722299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of Multitargeted Polymer-Based Contrast Agents with Photoacoustic Computed Tomography: An Imaging Technique to Visualize Breast Cancer Intratumor Heterogeneity.
    Li L; Patil D; Petruncio G; Harnden KK; Somasekharan JV; Paige M; Wang LV; Salvador-Morales C
    ACS Nano; 2021 Feb; 15(2):2413-2427. PubMed ID: 33464827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
    Fan M; Cui Y; You C; Liu L; Gu Y; Peng W; Bai Q; Gao X; Li L
    Radiology; 2022 Mar; 302(3):516-524. PubMed ID: 34846204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.
    Ran X; Xiao J; Zhang Y; Teng H; Cheng F; Chen H; Zhang K; Sun Z
    Ther Adv Med Oncol; 2020; 12():1758835920977117. PubMed ID: 33425025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer.
    Zhou J; Xie T; Shan H; Cheng G
    Radiat Oncol; 2023 Jul; 18(1):117. PubMed ID: 37434241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.
    Yang C; Zhang S; Cheng Z; Liu Z; Zhang L; Jiang K; Geng H; Qian R; Wang J; Huang X; Chen M; Li Z; Qin W; Xia Q; Kang X; Wang C; Hang H
    Genome Med; 2022 Dec; 14(1):142. PubMed ID: 36527145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
    Sung JY; Shin HT; Sohn KA; Shin SY; Park WY; Joung JG
    PLoS One; 2019; 14(7):e0219682. PubMed ID: 31310640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
    Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
    Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.